Objectives: Most therapies for Hyperhidrosis of underarms are either effective temporarily or surgical Treatments. Three non surgical Treatments are evaluated and compared based on literature Research and own experience: Microneedeling RF, HIFU and Microwaves.
Introduction: Primary axillary hyperhidrosis (PAH) is a chronic idiopathic disorder causing major stress in patients. Hyperhidrosis is the production of sweat above and beyond normal physiological needs, regardless of the ambient temperature, and it affects > 4% of the population. In addition, a poll showed up to 21% of the population is bothered on a daily basis by their amount of underarm sweating. Despite the large number of patients who suffer from hyperhidrosis, there are relatively few effective nonsurgical treatment options Currently, the most widely prescribed treatment for AH is botulinum toxin, a
Results: The microwave device can fibrose eccrine and apocrine glands, achieving possibly permanent results. The procedure should preferably be performed under tumescent anesthesia. Side effects, principally local inflammation, are transient. Clinical effectiveness and safety, supported by recently published studies, position this technique as a first-choice option both for hyperhidrosis and for bromhidrosis.
Conclusion: Recent Studies evaluated the efficacy and safety of another EBD solution for hyperhidrosis: fractional microneedle radiofrequency (FMR) as an alternative permanent treatment for PAH with long-term follow-up
The Hyperhidrosis disease severity scale HDSS demonstrated significant improvement after treatment in the treatment group compared to the sham control. Follow-up results show that there were 10 patients (41.6%) with no relapse and 11 patients (45.9%) with relapse after 1 year. There was a significant correlation between HDSS changes in relapse and body mass index (BMI) (P = 0.03). Conclusi
利益冲突声明
您有否接受任何资金来支持研究这个主题？
否
您是否接受过关于这项研究的任何酬金或其他报酬？
否
你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否
你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
